Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of ART Initiation in HIV/TB Co-infected Patients (SAPIT)
NCT00398996Phase 3Completed
- Sponsor
- CAPRISA
- Start
- Jun 2005
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of didanosine, lamivudine, efavirenz in human immunodeficiency virus infection (HIV), sponsored by CAPRISA. Started Jun 2005; status: completed.
02
Drugs
didanosinelamivudineefavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00398996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00398996.